mazindol has been researched along with Chronic Insomnia in 2 studies
Mazindol: Tricyclic anorexigenic agent unrelated to and less toxic than AMPHETAMINE, but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Enzi, G | 1 |
| Baritussio, A | 1 |
| Marchiori, E | 1 |
| Crepaldi, G | 1 |
| Sedgwick, JP | 1 |
2 trials available for mazindol and Chronic Insomnia
| Article | Year |
|---|---|
Short-term and long-term clinical evaluation of a non-amphetaminic anorexiant (mazindol) in the treatment of obesity.
Topics: Adolescent; Adult; Anxiety; Diet, Reducing; Drug Evaluation; Glucose Tolerance Test; Humans; Indoles | 1976 |
Maziniol in the treatment of obesity.
Topics: Body Weight; Clinical Trials as Topic; Constipation; Humans; Indoles; Mazindol; Obesity; Placebos; S | 1975 |